These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31566876)

  • 1. United States donation after circulatory death liver transplantation is driven by a few high-utilization transplant centers.
    Hobeika MJ; Menser T; Nguyen DT; Beal LL; Zajac S; Graviss EA
    Am J Transplant; 2020 Jan; 20(1):320-321. PubMed ID: 31566876
    [No Abstract]   [Full Text] [Related]  

  • 2. A cost comparison of liver acquisition fees for donation after circulatory death versus donation after brain death donors.
    Wall AE; Da Graca B; Asrani SK; Ruiz R; Fernandez H; Gupta A; Martinez E; Bayer J; McKenna G; He Lee S; Trotter JF; Testa G
    Liver Transpl; 2024 Aug; 30(8):775-784. PubMed ID: 38190240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Current State of Liver Transplantation in the United States: Perspective From American Society of Transplant Surgeons (ASTS) Scientific Studies Committee and Endorsed by ASTS Council.
    Fayek SA; Quintini C; Chavin KD; Marsh CL
    Am J Transplant; 2016 Nov; 16(11):3093-3104. PubMed ID: 27545282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Quality and Utilization in Controlled Donation After Circulatory Determination of Death Within the United States.
    Mooney JJ; Hedlin H; Mohabir PK; Vazquez R; Nguyen J; Ha R; Chiu P; Patel K; Zamora MR; Weill D; Nicolls MR; Dhillon GS
    Am J Transplant; 2016 Apr; 16(4):1207-15. PubMed ID: 26844673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again.
    Cascales-Campos PA; Ferreras D; Alconchel F; Febrero B; Royo-Villanova M; Martínez M; Rodríguez JM; Fernández-Hernández JÁ; Ríos A; Pons JA; Sánchez-Bueno F; Robles R; Martínez-Barba E; Martínez-Alarcón L; Parrilla P; Ramírez P
    Am J Transplant; 2020 Jan; 20(1):204-212. PubMed ID: 31329359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.
    Scalea JR; Redfield RR; Arpali E; Leverson GE; Bennett RJ; Anderson ME; Kaufman DB; Fernandez LA; D'Alessandro AM; Foley DP; Mezrich JD
    Am J Transplant; 2017 Jan; 17(1):191-200. PubMed ID: 27375072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement.
    Croome KP; Daneshmand MA
    Am J Transplant; 2021 Feb; 21(2):484-487. PubMed ID: 32956516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noneligible Donors as a Strategy to Decrease the Organ Shortage.
    Croome KP; Lee DD; Keaveny AP; Taner CB
    Am J Transplant; 2017 Jun; 17(6):1649-1655. PubMed ID: 27977900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a National Controlled Donation After Circulatory Death (DCD) Program on Organ Donation in the United Kingdom: A 10-Year Study.
    Hodgson R; Young AL; Attia MA; Lodge JPA
    Am J Transplant; 2017 Dec; 17(12):3172-3182. PubMed ID: 28556608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agree on much, except it is time for change.
    Samstein B; McElroy LM
    Am J Transplant; 2019 Jul; 19(7):1912-1916. PubMed ID: 30884119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPTN/SRTR 2017 Annual Data Report: Deceased Organ Donation.
    Israni AK; Zaun D; Rosendale JD; Schaffhausen C; Snyder JJ; Kasiske BL
    Am J Transplant; 2019 Feb; 19 Suppl 2():485-516. PubMed ID: 30811886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of incorporating standardized, verifiable, objective metrics of organ procurement organization performance into discussions about organ allocation.
    Goldberg D; Karp S; Shah MB; Dubay D; Lynch R
    Am J Transplant; 2019 Nov; 19(11):2973-2978. PubMed ID: 31199562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donation after circulatory death donor allografts on outcomes following liver transplantation for fulminant hepatic failure in the United States.
    Kumar S; Lin S; Schold JD
    Am J Transplant; 2021 Jan; 21(1):382-390. PubMed ID: 32865321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to "Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again".
    Cascales-Campos PA; Ferreras D; Alconchel F; Febrero B; Royo-Villanova M; Martínez M; Rodríguez JM; Fernández-Hernández JÁ; Ríos A; Pons JA; Sánchez-Bueno F; Robles R; Martínez-Barba E; Martínez-Alarcón L; Parrilla P; Ramírez P
    Am J Transplant; 2020 Feb; 20(2):615-616. PubMed ID: 31665551
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.
    Croome KP; Mathur AK; Lee DD; Moss AA; Rosen CB; Heimbach JK; Taner CB
    Transplantation; 2018 Jul; 102(7):1108-1114. PubMed ID: 29952924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we mitigate the effects of simultaneous liver-kidney transplantation through increased utilization of HCV-positive donors?
    Sibulesky L; Perkins JD; Landis CS; Johnson CK
    Am J Transplant; 2018 Oct; 18(10):2604-2605. PubMed ID: 30102461
    [No Abstract]   [Full Text] [Related]  

  • 17. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool.
    Selck FW; Grossman EB; Ratner LE; Renz JF
    Ann Surg; 2008 Oct; 248(4):599-607. PubMed ID: 18936573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined lung and liver procurement in controlled donation after circulatory death using normothermic abdominal perfusion. Initial experience in two Spanish centers.
    Miñambres E; Ruiz P; Ballesteros MA; Álvarez C; Cifrián JM; Atutxa L; Ventoso A; Castillo F; Gastaca M
    Am J Transplant; 2020 Jan; 20(1):231-240. PubMed ID: 31265753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobile ECMO team for controlled donation after circulatory death.
    Pérez-Villares JM; Lara-Rosales R; Fernández-Carmona A; Fuentes-Garcia P; Burgos-Fuentes M; Baquedano-Fernández B
    Am J Transplant; 2018 May; 18(5):1293-1294. PubMed ID: 29316269
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of the procurement surgeon on transplanted abdominal organ outcomes: An SRTR analysis to evaluate regional organ procurement collaboration.
    Serrano OK; Vock DM; Snyder JJ; Chinnakotla S; Kandaswamy R; Pruett TL; Matas AJ; Finger EB
    Am J Transplant; 2019 Aug; 19(8):2219-2231. PubMed ID: 30748093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.